Literature DB >> 31082450

Dopamine β Hydroxylase (DBH) is a potential modifier gene associated with Parkinson's disease in Eastern India.

Arunibha Ghosh1, Tamal Sadhukhan1, Subhajit Giri1, Arindam Biswas1, Shyamal Kumar Das2, Kunal Ray3, Jharna Ray4.   

Abstract

BACKGROUND: Parkinson's disease (PD) is the debilitating movement disorder, distinguished by dopaminergic and norepinephrinergic neurodegeneration. Apart from candidate gene mutations, several modifier loci have been reported to be associated with the disease manifestation. The Dopamine β-Hydroxylase (DBH) maintains cellular dopamine content and regulates dopamine turn over in neurons. Genetic polymorphisms of DBH are associated with PD and are found to alter plasma DBH activity in patients compared to healthy controls. Therefore, DBH activity in plasma could be a potential and easily detectable biomarkers for alteration of dopaminergic neuronal function in PD.
METHODS: Plasma DBH activity has been assessed among PD cases and age-matched controls to identify correlation with PD. To elucidate the role of DBH polymorphisms in Eastern Indian PD patients, three SNPs (rs1611115, rs1108580 and rs129882) were selected and screened by PCR-RFLP and DNA sequencing analysis.
RESULTS: The T-allele of rs129882 was more prevalent among patients than controls posing risk (p-value = 0.02, OR = 1.404, 95% CI = 1.047-1.883) towards PD. The dual-Luciferase assay in SHSY5Y cell line revealed that the T-allele of rs129882 increases Luciferase signal (p =  0.0269). However, the rs1611115 and rs1108580 did not show association with PD; plasma DBH activity was not significantly different between patients and controls (p-value > 0.05). Haplotypes constructed with three SNPs showed that the CAT haplotype to pose risk, TAC haplotype to provide protection against early disease onset and CGT being protective against non-motor symptoms.
CONCLUSION: These data suggest that DBH might influence the susceptibility of PD.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  DBH; Dopaminergic; Neurodegeneration; Norepinephrinergic; Parkinson’s disease

Mesh:

Substances:

Year:  2019        PMID: 31082450     DOI: 10.1016/j.neulet.2019.05.015

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Genomic, transcriptomic, and metabolomic profiles of hiPSC-derived dopamine neurons from clinically discordant brothers with identical PRKN deletions.

Authors:  Holly N Cukier; Hyunjin Kim; Anthony J Griswold; Simona G Codreanu; Lisa M Prince; Stacy D Sherrod; John A McLean; Derek M Dykxhoorn; Kevin C Ess; Peter Hedera; Aaron B Bowman; M Diana Neely
Journal:  NPJ Parkinsons Dis       Date:  2022-06-29

2.  Association between 19-bp Insertion/Deletion Polymorphism of Dopamine β-Hydroxylase and Autism Spectrum Disorder in Thai Patients.

Authors:  Wikrom Wongpaiboonwattana; Areerat Hnoonual; Pornprot Limprasert
Journal:  Medicina (Kaunas)       Date:  2022-09-06       Impact factor: 2.948

3.  Association Analyses of SNAP25, HNMT, FCHSD1, and DBH Single-Nucleotide Polymorphisms with Parkinson's Disease in a Northern Chinese Population.

Authors:  Cuiyun Dai; Yichi Zhang; Xiaoni Zhan; Meihui Tian; Hao Pang
Journal:  Neuropsychiatr Dis Treat       Date:  2021-05-27       Impact factor: 2.570

4.  Modelling the pathogenesis of X-linked distal hereditary motor neuropathy using patient-derived iPSCs.

Authors:  Gonzalo Perez-Siles; Anthony Cutrupi; Melina Ellis; Jakob Kuriakose; Sharon La Fontaine; Di Mao; Motonari Uesugi; Reinaldo I Takata; Carlos E Speck-Martins; Garth Nicholson; Marina L Kennerson
Journal:  Dis Model Mech       Date:  2020-01-13       Impact factor: 5.758

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.